Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors? [1]

International Journal of Colorectal Disease

Volumn 22, Issue 8, 2007, Pages 981-982

  Wasserberg, Nir ^a   Nunoo Mensah, Joseph W ^a   Beart Jr , Robert W ^a   Ker, Tim S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; STEM CELL FACTOR RECEPTOR;

ADJUVANT THERAPY; AGED; ASIAN; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DEFECATION DISORDER; DIGITAL RECTAL EXAMINATION; DRUG WITHDRAWAL; DYSURIA; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; LETTER; LOWER ABDOMINAL PAIN; MALE; MITOSIS RATE; PELVIS PAIN SYNDROME; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RASH; RECTOSCOPY; RECTUM ANTERIOR RESECTION; RECTUM BIOPSY; RECTUM TUMOR; SMALL INTESTINE OBSTRUCTION; SPINDLE CELL CARCINOMA; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; NEOADJUVANT THERAPY; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 34250698910     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0104-y     Document Type: Letter

References (0)